Geyer, Mark

Publications

Sort by

Co-Author Network

Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy. Molecular therapy : the journal of the American Society of Gene Therapy. 2018 Academic Article GET IT
Times cited: 64
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia. Bone marrow transplantation. 2018 Academic Article GET IT
Times cited: 3
Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells. Leukemia & lymphoma. 2017 Article GET IT
Times cited: 6
Digging deeper in relapsed acute lymphoblastic leukemia: impact of MRD status on outcome in second remission. Leukemia & lymphoma. 2017 Article GET IT
Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis. Blood. 2017 Article GET IT
Times cited: 75
Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells. Cytotherapy. 2016 Information Resource GET IT
Times cited: 80
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood. 2016 Information Resource GET IT
Times cited: 322